{"id":14965,"date":"2012-06-12T08:30:00","date_gmt":"2012-06-12T06:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/ema-celebra-il-millesimo-medicinale-orfano\/"},"modified":"2012-06-12T08:30:00","modified_gmt":"2012-06-12T06:30:00","slug":"ema-celebra-il-millesimo-medicinale-orfano","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/ema-celebra-il-millesimo-medicinale-orfano\/","title":{"rendered":"Ema celebrates the thousandth orphan drug"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: BookAntiqua; color: #212120; font-size: 12pt; mso-bidi-font-family: BookAntiqua\"><font face=\"Calibri\">Designation of orphan drug number 1000 by the European Medicines Agency (EMA), a system that allows companies that develop medicines for patients with rare diseases to benefit from a series of incentives. They - recalls the EMA - include development assistance, reduced fees for regulatory procedures and commercial protection once the product reaches the market. Organ drug designations are granted by the European Commission on the recommendation of EMA&#039;s Committee for Orphan Medicinal Products. This measure was introduced in 1999 to stimulate the development of research into diseases that would otherwise have been forgotten by industry, despite the fact that around 30 million Europeans live with a rare disease, which affects 5 out of 10,000 people. The equivalent of about 250,000 patients for each pathology.<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><i><span style=\"line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; color: #212120; font-size: 9pt; mso-bidi-font-weight: bold\">June 12, 2012 \u2013 PharmaKronos<\/span><\/i><span style=\"line-height: 115%; font-family: BookAntiqua; color: #212120; font-size: 9pt; mso-bidi-font-family: BookAntiqua\"><font face=\"Calibri\"> <\/p>\n<p><\/font><\/span><\/p>\n<p style=\"text-align: left\">&nbsp;<img decoding=\"async\" id=\"rg_hi\" class=\"rg_hi uh_hi\" alt=\"\" data-height=\"155\" data-width=\"324\" style=\"width: 177px; height: 69px\" src=\"https:\/\/encrypted-tbn0.google.com\/images?q=tbn:ANd9GcRoYhQQ-Wb0wGXpj0z-7j4WdCSKoVaRzeFWnYohOatRz7twj-PWCw\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>Designazione di farmaco orfano numero 1000 alla European Medicines Agency (Ema), un sistema che consente alle aziende che sviluppano medicinali destinati a pazienti con malattie rare di beneficiare di una serie di incentivi. Essi &#8211; ricorda l&#8217;Ema &#8211; includono l&#8217;assistenza allo sviluppo, tasse ridotte per le procedure regolatorie e protezione commerciale una volta che il &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14965","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14965"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14965\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}